Tag: iga

Topical Ruxolitinib Found Safe, Effective in 52-Week AD Study

After treatment with ruxolitinib cream for 52 weeks, between 60% and 80% of atopic dermatitis patients maintained clear or almost clear skin, with no safety...

Emollient Data Discouraging for Atopic Dermatitis Prevention

Emollients don’t prevent atopic dermatitis (AD), but they might have untapped potential as treatment, two new studies suggest. The results of a prevention study, in...

Delgocitinib Successful for Hand Eczema in Phase 2b Trial

Delgocitinib cream shows a dose-dependent response in easing chronic hand eczema, a common and difficult-to-treat disorder for which few other topical options are available, new...

India hopes for early operationalisation of IGA with Russia to manufacture defence spare parts

New Delhi: India has expressed hope that the Inter-Governmental Agreement (IGA) with Russia to manufacture spare parts of defence equipment here will be operationalised soon....

‘Sweet Spot’ for Antibody Tests is 3 to 4 Weeks Postexposure

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The Infectious Diseases Society of America (IDSA) is recommending against testing...